148 related articles for article (PubMed ID: 18167351)
1. Endophilin I expression is increased in the brains of Alzheimer disease patients.
Ren Y; Xu HW; Davey F; Taylor M; Aiton J; Coote P; Fang F; Yao J; Chen D; Chen JX; Yan SD; Gunn-Moore FJ
J Biol Chem; 2008 Feb; 283(9):5685-91. PubMed ID: 18167351
[TBL] [Abstract][Full Text] [Related]
2. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.
Yao J; Taylor M; Davey F; Ren Y; Aiton J; Coote P; Fang F; Chen JX; Yan SD; Gunn-Moore FJ
Mol Cell Neurosci; 2007 Jun; 35(2):377-82. PubMed ID: 17490890
[TBL] [Abstract][Full Text] [Related]
3. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
Yan SD; Stern DM
Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
[TBL] [Abstract][Full Text] [Related]
7. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
[TBL] [Abstract][Full Text] [Related]
8. Endophilin 1 knockdown prevents synaptic dysfunction induced by oligomeric amyloid β.
Yin Y; Cha C; Wu F; Li J; Li S; Zhu X; Zhang J; Guo G
Mol Med Rep; 2019 Jun; 19(6):4897-4905. PubMed ID: 31059028
[TBL] [Abstract][Full Text] [Related]
9. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
10. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
Zakaria A; Hamdi N; Abdel-Kader RM
Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
[TBL] [Abstract][Full Text] [Related]
11. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
Akhter R; Sanphui P; Das H; Saha P; Biswas SC
J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
[TBL] [Abstract][Full Text] [Related]
12. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
13. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
[TBL] [Abstract][Full Text] [Related]
14. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.
Morsy A; Maddeboina K; Gao J; Wang H; Valdez J; Dow LF; Wang X; Trippier PC
ACS Chem Neurosci; 2022 Jul; 13(14):2176-2190. PubMed ID: 35802826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.
Braithwaite SP; Schmid RS; He DN; Sung ML; Cho S; Resnick L; Monaghan MM; Hirst WD; Essrich C; Reinhart PH; Lo DC
Neurobiol Dis; 2010 Sep; 39(3):311-7. PubMed ID: 20451607
[TBL] [Abstract][Full Text] [Related]
16. JNK activation is associated with intracellular beta-amyloid accumulation.
Shoji M; Iwakami N; Takeuchi S; Waragai M; Suzuki M; Kanazawa I; Lippa CF; Ono S; Okazawa H
Brain Res Mol Brain Res; 2000 Dec; 85(1-2):221-33. PubMed ID: 11146125
[TBL] [Abstract][Full Text] [Related]
17. Ovariectomy increases neuronal amyloid-beta binding alcohol dehydrogenase level in the mouse hippocampus.
Fukuzaki E; Takuma K; Funatsu Y; Himeno Y; Kitahara Y; Gu B; Mizoguchi H; Ibi D; Koike K; Inoue M; Yan SD; Yamada K
Neurochem Int; 2008 Jun; 52(7):1358-64. PubMed ID: 18387708
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.
Tsukamoto E; Hashimoto Y; Kanekura K; Niikura T; Aiso S; Nishimoto I
J Neurosci Res; 2003 Sep; 73(5):627-36. PubMed ID: 12929130
[TBL] [Abstract][Full Text] [Related]
19. 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.
Telerman A; Ofir R; Kashman Y; Elmann A
BMC Complement Altern Med; 2017 Jun; 17(1):332. PubMed ID: 28645294
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
